Kura Oncology, Inc.
KURA
$9.88
-$0.29-2.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -216.88M | -197.17M | -181.89M | -173.98M | -197.55M |
| Total Depreciation and Amortization | 833.00K | 877.00K | 855.00K | 848.00K | 858.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.95M | 20.79M | 21.23M | 21.28M | 19.95M |
| Change in Net Operating Assets | 278.90M | 300.50M | 271.04M | 286.17M | 7.63M |
| Cash from Operations | 87.80M | 124.99M | 111.23M | 134.32M | -169.12M |
| Capital Expenditure | -4.69M | -2.12M | -680.00K | -472.00K | -116.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -38.77M | -89.77M | -106.98M | -101.12M | 35.68M |
| Cash from Investing | -43.46M | -91.89M | -107.66M | -101.59M | 35.56M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.46M | 3.67M | 6.19M | 154.42M | 154.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.46M | 3.67M | 6.19M | 154.42M | 154.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.81M | 36.77M | 9.76M | 187.14M | 20.74M |